Common Contracts
12 similar Executive Employment Agreement contracts by Kura Oncology, Inc.
Executive Employment Agreement for Brian PowlExecutive Employment Agreement • November 2nd, 2023 • Kura Oncology, Inc. • Pharmaceutical preparations • California
This Executive Employment Agreement (the “Agreement”), entered into between Kura Oncology, Inc. (the “Company”) and Brian Powl (the “Executive”) (collectively, the “Parties”), is effective as of August 14, 2023 (the “Effective Date”).
Kura Oncology, Inc. Executive Employment Agreement for Bridget MartellExecutive Employment Agreement • May 6th, 2021 • Kura Oncology, Inc. • Pharmaceutical preparations • California
This Executive Employment Agreement (the “Agreement”), entered into between Kura Oncology, Inc. (the “Company”) and Bridget Martell (the “Executive”) (collectively, the “Parties”), is effective as of February 10, 2020 (the “Effective Date”).
Kura Oncology, Inc. Executive Employment Agreement for Stephen Dale, M.D.Executive Employment Agreement • May 6th, 2021 • Kura Oncology, Inc. • Pharmaceutical preparations • California
This Executive Employment Agreement (the “Agreement”), entered into between Kura Oncology, Inc. (the “Company”) and Stephen Dale (the “Executive”) (collectively, the “Parties”), is effective as of July 22, 2020 (the “Effective Date”).
Kura Oncology, Inc. Executive Employment Agreement for Kirsten FlowersExecutive Employment Agreement • May 6th, 2021 • Kura Oncology, Inc. • Pharmaceutical preparations • California
This Executive Employment Agreement (the “Agreement”), entered into between Kura Oncology, Inc. (the “Company”) and Kirsten Flowers (the “Executive”) (collectively, the “Parties”), is effective as of January 6, 2020 (the “Effective Date”).
Kura Oncology, Inc. Executive Employment Agreement for James BastaExecutive Employment Agreement • May 4th, 2020 • Kura Oncology, Inc. • Pharmaceutical preparations • California
This Executive Employment Agreement (the “Agreement”), entered into between Kura Oncology, Inc. (the “Company”) and James Basta (the “Executive”) (collectively, the “Parties”), is effective as of November 4, 2019 (the “Effective Date”).
Kura Oncology, Inc. Executive Employment Agreement for Kathleen FordExecutive Employment Agreement • November 5th, 2019 • Kura Oncology, Inc. • Pharmaceutical preparations • California
This Executive Employment Agreement (the “Agreement”), entered into between Kura Oncology, Inc. (the “Company”) and Kathleen Ford (the “Executive”) (collectively, the “Parties”), is effective as of August 9, 2019 (the “Effective Date”).
Kura Oncology, Inc. Executive Employment Agreement for Marc GrassoExecutive Employment Agreement • November 5th, 2018 • Kura Oncology, Inc. • Pharmaceutical preparations • California
This Executive Employment Agreement (the “Agreement”), entered into between Kura Oncology, Inc. (the “Company”) and Marc Grasso (the “Executive”) (collectively, the “Parties”), is effective as of August 21, 2018 (the “Effective Date”).
Kura Oncology, Inc. Executive Employment Agreement for John FarnamExecutive Employment Agreement • August 6th, 2018 • Kura Oncology, Inc. • Pharmaceutical preparations • California
This Executive Employment Agreement (the “Agreement”), entered into between Kura Oncology, Inc. (the “Company”) and John Farnam(the “Executive”) (collectively, the “Parties”), is effective as of July 1, 2018 (the “Effective Date”).
Kura Oncology, Inc. Amended and Restated Executive Employment Agreement for Heidi HensonExecutive Employment Agreement • March 12th, 2018 • Kura Oncology, Inc. • Pharmaceutical preparations • California
This Amended and Restated Executive Employment Agreement (the “Agreement”), entered into between Kura Oncology, Inc. (the “Company”) and Heidi Henson (the “Executive”) (collectively, the “Parties”), is effective as of January 29, 2016 (the “Effective Date”). As of the Effective Date, this Agreement amends, restates and supersedes in its entirety the Executive Employment previously entered into by the Parties on October 1, 2014 and amended on May 12, 2015 (together, the “Prior Agreement”).
Kura Oncology, Inc. Amended and Restated Executive Employment Agreement for Troy E. WilsonExecutive Employment Agreement • March 17th, 2016 • Kura Oncology, Inc. • Pharmaceutical preparations • California
This Amended and Restated Executive Employment Agreement (the “Agreement”), entered into between Kura Oncology, Inc. (the “Company”) and Troy E. Wilson, Ph.D., J.D., (the “Executive”) (collectively, the “Parties”), is effective as of January 29, 2016 (the “Effective Date”). As of the Effective Date, this Agreement amends, restates and supersedes in its entirety the Executive Employment previously entered into by the Parties on October 1, 2014 and amended on May 12, 2015 (together, the “Prior Agreement”).
Kura Oncology, Inc. Amended and Restated Executive Employment Agreement for Annette NorthExecutive Employment Agreement • March 17th, 2016 • Kura Oncology, Inc. • Pharmaceutical preparations • California
This Amended and Restated Executive Employment Agreement (the “Agreement”), entered into between Kura Oncology, Inc. (the “Company”) and Annette North (the “Executive”) (collectively, the “Parties”), is effective as of January 29, 2016 (the “Effective Date”). As of the Effective Date, this Agreement amends, restates and supersedes in its entirety the Executive Employment previously entered into by the Parties on January 12, 2015 and amended on May 12, 2015 (together, the “Prior Agreement”).
Kura Oncology, Inc. Amended and Restated Executive Employment Agreement for Antonio GualbertoExecutive Employment Agreement • March 17th, 2016 • Kura Oncology, Inc. • Pharmaceutical preparations • California
This Amended and Restated Executive Employment Agreement (the “Agreement”), entered into between Kura Oncology, Inc. (the “Company”) and Antonio Gualberto (the “Executive”) (collectively, the “Parties”), is effective as of January 29, 2016 (the “Effective Date”). As of the Effective Date, this Agreement amends, restates and supersedes in its entirety the Executive Employment previously entered into by the Parties on October 1, 2014 and amended on May 12, 2015 (together, the “Prior Agreement”).
